title: Do anti-TNF agents and combination treatment increase postoperative complication risk?
authors.affiliation: Department of Gastroenterology, Memorial Hospital, Piyalepaşa Bulvarı, 34385 Şişli, İstanbul, Turkey. oya.yonal@memorial.com.tr
authors.forename: Oya
authors.initials: O
authors.lastname: Yönal
authors.forename: Gülen
authors.initials: G
authors.lastname: Hatemi
authors.forename: Över
authors.initials: Ö
authors.lastname: Hamzaoğlu
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D011183:Postoperative Complications / Q000139:chemically induced / Q000453:epidemiology*; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab